| 常用名 | Capmatinib hydrochloride | CAS号 | 1865733-40-9 |
|---|---|---|---|
| 价格 | 纯度 | 99.84% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Capmatinib (INC280; INCB28060) dihydrochloride hydrate is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor (IC50=0.13 nM). Capmatinib dihydrochloride hydrate can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib dihydrochloride hydrate potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Capmatinib dihydrochloride hydrate is largely metabolized by CYP3A4 and aldehyde oxidase[1][2][3]. 物理化学性质: CAS号:1865733-40-9 常用中文名:Capmatinib hydrochloride 常用英文名:Capmatinib hydrochloride 分子式:C23H21Cl2FN6O2 分子量:503.356 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |